Richard A. Young, Director at Syros Pharmaceuticals, Inc. (SYRS), sold 23,960 shares at $8.75 ($210K) on 2020-04-15, disclosed to the SEC on 2020-04-17.
Open-market sale of $210k SYRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OMGA | SELL | 2023-06-05 | $40K | — | Filing → |
| OMGA | SELL | 2023-05-03 | $40K | — | Filing → |
| OMGA | SELL | 2023-04-10 | $40K | — | Filing → |